satralizumab

Italy

Drugs containing this active substance

  • ENSPRYNG

    It is used to treat neuromyelitis optica spectrum disorder (NMOSD) in adults and young people aged 12 years and older. It works by blocking a protein called interleukin-6 to reduce the risk of disease attacks or relapses.

    Form: solution for injection

    Active substance Dosage
    satralizumab -

    ATC: L04AC19

    Manufacturer: ROCHE REGISTRATION GMBH